Jefferies initiates Kodiak Sciences stock with Buy rating, $15 target
PositiveFinancial Markets

Jefferies has initiated coverage of Kodiak Sciences with a Buy rating and set a target price of $15 per share. This positive outlook reflects confidence in Kodiak's potential for growth and innovation in the biotech sector, which could attract investors looking for promising opportunities. The firm's endorsement may also enhance Kodiak's visibility in the market, potentially leading to increased interest from both institutional and retail investors.
— Curated by the World Pulse Now AI Editorial System